McGill University, Montreal, Quebec.
Pain Res Manag. 2005 Autumn;10 Suppl A:27A-30A. doi: 10.1155/2005/847562.
Over the past five years, there has been a considerable increase in clinical research on cannabinoid use for a range of pain syndromes. Cannabinoid products are becoming available for research and clinical use, and pharmaceutical industry interest in the potential for cannabinoids in therapeutics is also gaining momentum. The present article summarizes recent clinical trial data in the field of pain management and suggests that the potential for cannabinoid therapy for chronic pain states is encouraging. Clinicians working in pain management should be aware of the options becoming available from the cannabinoid class of medications.
在过去的五年中,大麻素治疗各种疼痛综合征的临床研究有了相当大的增长。大麻素产品可用于研究和临床使用,制药行业对大麻素在治疗中的潜力的兴趣也在增强。本文总结了疼痛管理领域的最新临床试验数据,表明大麻素治疗慢性疼痛状态的潜力令人鼓舞。从事疼痛管理的临床医生应该了解大麻素类药物的可用选择。